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(57) ABSTRACT 
A high-pressure hollow cathode ionizer is combined with an 
ion-mobility-spectrometer (IMS) for the detection of trace 
amounts of organic compounds in gas. The ionizer uses 
H,O+, ions which do not react with air to ionize the organic 
compounds and the organic compounds are soft ionized. The 
ionized organic compounds are detected in the IMS at levels 
of parts per billion and identified using calibrated reference 
tables. Applications include but are not limited to the fields 
of  (1) medicine as a breath analyzer for detection of lung 
cancer, diabetes, liver cirrhosis, (2) law enforcement in drug 
interdiction and explosives detection, (3) food monitoring 
and control, (4) environmental monitoring and (5) space 
applications. 
20 Claims, 4 Drawing Sheets 
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PROTON-TRANSFER-REACTION/ION- 
MOBILITY-SPECTROMETER AND METHOD 
OF USING THE SAME 
RELATED APPLICATIONS 
The present application is related to U.S. Provisional 
Patent Application serial No. 601334,437, filed on Nov. 30, 
2001, which is incorporated herein by reference and to 
which priority is claimed pursuant to 35 USC 119. 
The present application was funded at least in part by 
NASAfunding pursuant to Grant No. NAS7-1407 and may 
be subject to government rights. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The invention relates to the field of ionizers combined 
with ion-mobility spectrometers (IMS) for the detection of 
trace amounts of organic compounds in gas and methods of 
using the same. 
2. Description of the Prior Art 
Miniature mass spectrometry is a powerful in-situ tool for 
identifying a wide variety of chemical compounds. For 
applications that cover many disciplines such as planetary 
exploration, residual gas analysis, and environmental 
applications, there is a need for an in-situ analytical sepa- 
ration device or chemical sensor which is rugged, light 
weight, low power, small, fast, and requires minute quanti- 
ties of sample for analysis. These requirements are also 
applicable for the detection of certain organics in the medi- 
cal sciences (analyzing human breath to detect compounds 
associated with certain deadly diseases such as lung cancer 
and cirrhosis of the liver), for a chemical sensor for use on 
the battlefield (chemical warfare agents), law enforcement 
(drug interdiction and explosives detection), and food moni- 
toring and control. 
Gas chromatographyimass spectrometry (GC/MS) is per- 
haps the most prominent of current techniques presently 
available for the analysis of organic compounds. However, 
conventional GC/MS detectors have three notable shortcom- 
ings. First there is limited sensitivity. Commonly used 
GC/MS detectors likely lack the sensitivity needed to detect 
organic compounds at the sub parts-per-billion (ppb) level, 
a necessity that should be a requirement for in-situ chemical 
analysis. Second, the fragmentation of large organic species 
prevents accurate identification of organic samples. When a 
mixture of organic components is to be analyzed, the com- 
plexity of breakup patterns puts very severe constraints on 
the quantitative analysis of the concentrations of these 
components. Third, strenuous vacuum requirements. In con- 
ventional GCiMS systems require a high vacuum environ- 
ment which greatly increases the size, weight and mechani- 
cal complexity. A new detector that will circumvent these 
problems (i.e. a detector which does not need a complicated 
vacuum system to operate, has detection sensitivity at levels 
below parts per-billion and is free from any fragmentation 
problem) is needed. 
BRIEF SUMMARY OF THE INVENTION 
The invention is an apparatus which combines a novel 
high-pressure (-1-5 Torr) hollowcathode ionizer and an 
ion-mobility-spectrometer (IMS) for the detection of trace 
amounts of organic compounds. The detector uses a novel 
“soft-ionization technique”, based on a proton-transfer reac- 
tion involving H,O+, to efficiently ionize (e.g. >95%) most 
large molecules without fragmentation. This is critical for 
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the unambiguous identification of species. In addition, H30’ 
ions do not react with clean air. The result is that the normal 
components of air (O,, N,, CO,, CO, and the like) pass 
through the detector and do not get detected with the spectra 
of most organic compounds.The advantages of this approach 
in comparison to commonly used gas chromatographyimass 
spectrometry (GC/MS) is extremely low background signal 
owing to the inherent filtering capabilities of our novel H,O+ 
ionization technique, increased sensitivity, no fragmentation 
of large organic species, and no high vacuum requirements. 
The unit can operate under atmospheric conditions. In 
addition, the cost of this unit is at the time of filing expected 
to be in the range of $3-6000, which is much less than 
typical GC/MS units. Finally, the instrumentation is rela- 
tively small. For example a laptop computer used to acquire 
the data is larger than the instrumentation and supporting 
electronics. Applications of the invention to the fields of  (1) 
medicine as a breath analyzer for detection of lung cancer, 
diabetes, liver cirrhosis, etc., (2) law enforcement in drug 
interdiction and explosives detection, (3) food monitoring 
and control, (4) environmental monitoring and (5) space 
applications such as searching chemical signatures of life on 
outer planets are expected to be substantial and only a very 
partial list were utility can be found. 
While the apparatus and method has or will be described 
for the sake of grammatical fluidity with functional 
explanations, it is to be expressly understood that the claims, 
unless expressly formulated under 35 USC 112, are not to be 
construed as necessarily limited in any way by the construc- 
tion of “means” or “steps” limitations, but are to be accorded 
the full scope of the meaning and equivalents of the defi- 
nition provided by the claims under the judicial doctrine of 
equivalents, and in the case where the claims are expressly 
formulated under 35 USC 112 are to be accorded full 
statutory equivalents under 35 USC 112. The invention can 
be better visualized by turning now to the following draw- 
ings wherein like elements are referenced by like numerals. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a block diagram of the combination of the 
ionizer, reaction chamber and IMS detector of the invention. 
FIG. 2 is a block diagram of the control and power 
circuitry associated with the combination of FIG. 1. 
FIGS. 3a-3d are graphs of the data output from the 
instrument of FIGS. 1 and 2. 
The invention and its various embodiments can now be 
better understood by turning to the following detailed 
description of the preferred embodiments which are pre- 
sented as illustrated examples of the invention defined in the 
claims. It is expressly understood that the invention as 
defined by the claims may be broader than the illustrated 
embodiments described below. 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENTS 
The invention is a small, portable detector system, gen- 
erally denoted by reference numeral 10 in FIG. 1, with high 
sensitivity in the range of subparts-per-billion and suitable 
for detection of a trace amount of organic compounds in a 
gas or air. The system design does not suffer from the 
problems normally associated with commonly used gas 
chromatographyimass spectrometry (GCIMS) based instru- 
ments such as limited sensitivity, fragmentation of large 
organic species and high vacuum requirements. System 10, 
which is light weight and consumes approximately 10 W 
power or less, is adapted, for example, for in-situ investi- 
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gations on planetary bodies. There is also a great potential to 
utilize system 10 with minor or no modification in medicine 
as breath analyzer for early detection of certain deadly 
diseases. Military and law enforcement applications also 
exist. Finally, use as an air quality detector aboard the space 
station is planned. Many more applications of system 10 
exist or can be devised and these categories do not exhaust 
the range of possibilities. 
One of the problems to which system 10 is directed is to 
provide a high sensitivity (ppb) detection technique for 
searching chemical signatures of life on planetary bodies, 
particularly on Mars. Therefore there was a need to develop 
and demonstrate a novel detection technique, which has 
distinct advantages over the commonly used GCiMS based 
instruments. System 10 possesses high sensitivity, does not 
suffer from a fragmentation problem of large organic species 
and significantly to planetary applications, it does not need 
high vacuum which greatly increases size, weight and 
mechanical complexity. 
What has been provided to meet this need is a system 10 
which combines a novel high-pressure (1-5 Torr) hollow 
cathode ionizer 12 and a conventional ion-mobility- 
spectrometer (IMS) 14. Although the specific IMS 14 used 
can be chosen according to the application requirements at 
hand, in the illustrated embodiment an IMS 14, made by the 
Jet Propulsion Laboratory located at Pasadena, Calif., is 
used. The details of IMS 14 are not critical to the invention 
and therefore will not be further described except to the 
extent necessary to provide an explanation of the relation- 
ship of the components. 
Ionizer 12 operates on the fundamental properties of the 
proton-transfer-reaction (PTR): 
RH++M=MH++R 
where RH’ is the reactant ion, H’ is a proton, R is the 
reactant gas, MH’ is a product ion and M is a molecule. The 
reactant molecule, R, can be chosen so that its proton affinity 
is slightly less than the proton affinity of the target molecule, 
M, in which case the probability for fragmentation channels 
of the reaction is low and the process of what is defined here 
as “soft” ionization is dominant. The process is called a soft 
ionization because the energy of the reaction does not 
fragment the molecule like in traditional electron-impact 
ionization. In addition, the molecule of interest is singly 
ionized and multiple ionization is substantially avoided. 
Thus, according to the invention, the voltages and currents 
employed in ionizer 12 as diagrammatically depicted in FIG. 
2 are modified to realize the soft or single ionization of only 
the class of molecules of interest, while leaving other 
molecules know or suspected to be present, which are not of 
interest, nonionized. 
Moreover, the reaction is highly selective i.e., molecules 
which have a proton affinity lower than the reactant do not 
enter the reaction. H,O+ is the most suitable proton donor for 
investigating trace components in the Martian air because 
these ions do not react with CO,, CO, H,O, 0,, N,, He, Ne, 
Ar, Xe etc. which are the prime constituents of present day 
Martian atmosphere. Many different choices of the reactant 
ion, RH’, other than H,O+, can be made according to 
teachings of the invention according to the molecule M to be 
detected. For example, the reactant ion is chosen according 
to the proton affinity of the molecule to be ionized. For 
example, if you seek to detect NO, in a N,O environment, 
SF,H+ (proton affinity 575 Himol) would be chosen as 
reactant ion, since N,O’s proton affinity (549 Himol) is 
smaller than for NO, (591 Himol). 
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IMS detection has been chosen for detecting trace 
amounts of ionized organic compounds because it provides 
benefits, which cannot be matched readily or reliably by 
other techniques. Notably, it possesses high sensitivity, 
which is defined here as detection limits in the low parts- 
per-billion range, offers a vastly improved molecular range, 
and does not require high vacuum for operation. 
The ionizer uses a high-pressure hollow cathode source 
(HOS) 12 to create reactant ions (H,O’) with a high purity. 
The hollow cathode discharge electrode system or source 12 
is comprised of a coaxial cylindrical hollow cathode 16 and 
anode 18 axially aligned with each other, which operate 
typically under approximately 1-5 Torr pressure provided 
by a vacuum pumping subsystem 11 communicated with gas 
inlet 20. Water vapor is supplied in small amounts from a 
water source 13 such as pressure storage tanks or vessels. 
The reactant gas is supplied though a small hole 36 in the 
bottom of reaction chamber 32. For example, for use in an 
air monitor aboard the space station, air is introduced 
through a small leak (-5 micron in diameter) where it will 
react with the H,O+ molecule and be detected. The nonion- 
ized reactant components are supplied through inlet 20 and 
if not ionized circulate in a closed system, exiting from 
ionizer 12 through gas outlet 22. Nonionized reactant com- 
ponents are circulated through the detector 14 for the 
purpose of ion mobility spectroscopy, which requires an 
inert drift gas to separate ions of differing mass. Aextraction 
lens 62 is located in front of IMS 14 so that ions can be 
extracted into the IMS 14. This allows for the reactant ions 
to be more localized in the reactant region. 
Anode 18 and cathode 16 coupled to a discharge power 
supply 44 shown diagrammatically in FIG. 2. The current 
supplied to anode 18 is in the illustrated embodiment of the 
order of 1 mA with the voltage potential between anode 18 
and cathode 16 held at about the order of 500 volts. Both 
discharge current and voltage are monitored by conventional 
ammeter 46 and voltmeter 48, respectively. The potential 
difference between anode 18 and sample probe 26 is moni- 
tored by ammeter 60 voltmeter 50 and is of the order of 800 
Volts. An accelerating voltage of the order of 100 volts from 
source 52 is applied to anode 18. Ammeter 60 is used for 
monitoring how much ion current is generated. Variable 
power supplies 54,56, and 58 are used to set the voltages to 
increase or decrease the ion current dependent on the appli- 
cation. Variable power supply 54 is coupled to anode 18, 
variable power supply 56 is coupled to sample probe 26 and 
variable power supply 58 is coupled to reaction chamber 34. 
Meters 46, 48, 50 and 60 are coupled to a software con- 
trolled computer 42, which acts as a control circuit to control 
power supplies 44, 52, 54, 56 and 58. Computer 42 could 
also be replaced by conventional logic and customized 
control circuitry if desired. 
When an ionized discharge is formed in the reactant gas, 
a relatively dense plasma is created in ionizer 12 which is 
comprised mostly of energetic electrons and reactant ions. 
The distribution of ions is axially symmetric in the embodi- 
ment of FIG. 1 where a symmetric ionizer 12 is used. Thus, 
the ions are easily extracted through a hole 24 in the center 
of one of the enclosing plates or sample probe 26, which is 
positioned practically “on” the plasma potential, because the 
bulk of the ionizing potential is concentrated in the cathode 
fall region 28. Plate 26 is also called the “sample probe”. The 
plasma potential is created by putting a potential on anode 
18 and cathode 16. This voltage, which is measured by 
voltmeter 48 at 5 Torr is on the order of 500 Volts. It turns 
out that this voltage is independent of the voltage generated 
by the discharge power supply 44. The extracted ions drift 
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through the ion source drift chamber 30 in ionizer 12. This spectra of four different prepared test mixtures. Peaks for 
type of ion source is much more efficient in generating pure each are marked with the corresponding constituent of the 
reactant ions than electron impact ionization sources. prepared test mixture, as determined from the calculated KO 
However, it is entirely within the scope of the invention to values of each peak with a comparison to that of known 
employ other types of ion sources now known or later s values of the corresponding constituent. 
devised for other embodiments of ionizer 12. Because the detector uses the most suitable proton donor, 
The gas sample to be analyzed is introduced into the which in the illustrated embodiment is H,O+ in the sense 
reaction region 32 of reaction chamber 34 where organic that there is no reaction with the components of air or those 
molecules undergo proton-transfer reactions and form posi- portions of the sample for which no reactions are sought, and 
tive ions or product ions with a high efficiency according to i o  is capable of identifying volatiles or organic molecules at the 
the reaction equation above. The proton transfer reaction ppb level, several applications have been identified includ- 
occurs between the ions in region 32, which are drifting in ing but not limited to medical uses (as a breath analyzer for 
the electric field along the axis of the chamber 34 or what is detection of lung cancer, diabetes, and liver cirrhosis, etc., 
defined here as the drift region 32, which is electric field law enforcement uses for drug interdiction and explosives 
created by means of two electrodes (not shown) maintained is detection, military uses such as chemical warfare agent 
by power supply 58 at different potentials, and target mol- detection, treaty verification, food monitoring and control 
ecules present in the gas sample introduced through sample and environmental monitoring uses, such as NASA space 
inlet 36. station air monitoring against hydrazine, waste incineration, 
The second component of system 10 is provided by means site remediation, fugitive emissions control. 
of ion mobility spectrometry (IMS) 14. IMS 14 provides 20 Some of these applications will now be described in 
detection and mass-analysis of the product ions MH' for greater detail. Potential markers for particular diseases (such 
organic compounds. The IMS detection technique has been as lung cancer, diabetes, liver cirrhosis, etc,) are usually 
chosen for detecting trace amounts of organic compounds, present in very low concentrations in the breath of patients 
because it provides benefits, which cannot be matched who are suffering from these diseases. In the onset of the 
readily or reliably by other techniques. Of particular zs diseases, these biomarkers are in extremely low 
importance, the IMS technique offers detection limits in the concentrations, nearly at the limit of existing instrumenta- 
parts-per-billion range. In addition, it offers a vastly tion. Research on new on-line highly sensitive analytical 
improved molecular range, and does not require a high methods is necessary to diagnose these deadly diseases 
vacuum for operation. The reactant ions RH' and product when they are still in their early, near-onset stages. 
ions MH' with specific polarity are caused to drift in the 30 Breath analysis has attracted scientific attention for more 
axial direction within system 10 by imposing an electric than 200 years: The breath of a guinea pig was analyzed and 
field by means of a bias voltage. Either positive or negative respiration and combustion processes were demonstrated to 
ions can be detected, depending on the polarity of the bias be analogous by Lavoisier and Laplace in 1784. More 
voltage. recently sensitive analyses have demonstrated several vola- 
In order to determine the drift velocity, the reactant ions 3s tile organic compounds (VOC's) in normal human breath, 
RH' are introduced into the drift region 32 of reaction many of which have been identified by gas chromatography 
chamber 34 in a pulsatile manner, i.e. time-dependent man- (GC) combined with mass spectrometry (MS). 
ner by means of providing a pulsed potential on sample Chemical analysis for VOC's in the breath yields infor- 
probe or plate 62. Within the drift region of the IMS detector mation about the pool of molecular compounds in the blood 
32, the product ions MH' will undergo spatial separation 40 that diffuse across the pulmonary alveolar membrane. These 
based on size, mass, and shape. For a given electric field E, compounds originate from two major sources: endogenous 
in drift region 32 the electric field in the entire drift region (i.e. products of metabolism) or exogenous (i.e. derived 
is constant in both time and position. The ion drift velocity from outside of the body). Consequently, breath analysis 
is directly proportional to the specific mobility of the prod- potentially presents a unique window on human metabolism, 
uct ions MH'. Smaller ions travel faster. and thus have 4s and simultaneouslv detects exuosure to volatile organic 
higher mobility than the larger ions that arrive later at input 
orifice 38 to IMS detector 14. By measuring the ion drift 
times for a particular set of conditions, one is then able to 
construct ion mobility reference tables that are used for 
identification of target ion species. In operation, the product SO 
ions MH' are introduced into the mass analyzer 14 via a 
series of pulses (repeated every 20 to 40 ms). A high-gain 
electrometer 40 in IMS 14 detects the resulting signal, which 
is typically at the pico-ampere (lo-'' A) level. A micropro- 
cessor 42 coupled to electrometer 40 handles data ss 
acquisition, processing, communication and display, as well 
v 
toxins in the environment, without incurring the discomfort 
or inconvenience of collection of body fluid. The concen- 
tration of VOC's in the alveolar airway suggests what the 
status of the patient's condition might be. Clinical diagnos- 
tics of breath was first reviewed by Manolis in 1983. He 
compiled a long list of diseases and ingestions associated 
with unusual odors. For example, breath acetone has been 
used successfully to monitor diabetics and patients on diets. 
Volatile sulfur organic compounds are increased in the 
breath of patients with periodontal disease. Other studies 
have also shown that certain diseases such as lung cancer, 
as control and monitoring of temperature and timing. Micro- liver cirrhosis, diabetes etc., result in VOC's in much higher 
processor 42 monitors temperature and pressure because in concentrations in unhealthy persons' breath than that of 
ion mobility spectroscopy the ion mobilities (KO) must be healthy ones. For example, higher concentrations of acetone, 
normalized to those at atmospheric pressure and tempera- 60 methylethylketone, n-propanol,  tolualdehyde and 
tures (KJ to be able to identify the ions. That is: oxepanone were found in the breath of patients who have 
lung cancer. Acetone concentration is greatly enhanced in 
the breath of persons suffering from diabetes. Similarly, 
propanol shows significantly enhanced concentrations in the 
More recently present physical and chemical studies of 
environmental determinants, suspected to cause the inci- 
K0=(T/273)(760/P)K, 
Where T is the Temperature in Kelvin, P is the Pressure 
in Torr. In the operation of instrument 10 K, is measured, 65 breath of cirrhosis patients. 
and related back to KO which is a fundamental number 
dependent on the ion. FIGS. 3a-3d are graphs of composite 
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dence of lung cancer, are predominantly oriented toward the 
substances present in the ambient air as particulates. Particle 
size, phase, and composition of various procarcinogane 
substances have been related to the inception of particular 
types of lung cancer. Little information exists on volatile, 
gas trace constituents of the human breath. This lack of 
information, combined with poorly developed present-day 
sampling techniques, ensures that most breath tests are of 
minor clinical value. However, it is the obvious fact, sensed 
by olfactory receptors, that odorous, volatile substances are 
present in the ambient air and in the exhaled human breath 
(in trace quantities) as well. 
The possibility that the expired air of patients with lung 
cancer might contain unique VOC’s that could be used as 
markers for screening, was first investigated by Gordon et al. 
in 1985. In their study of 12 samples from lung cancer 
patients and 17 control samples, they combined gas chro- 
matograph with multivariate statistical analysis to extract 
VOC’s. Samples of expired breath were collected by the gas 
chromatograpyimass spectrometry (GCIMS) methods and 
analyzed by using general computerized statistical proce- 
dures to distinguish lung cancer patients from controls. 
Gordon found 49 chemical compounds that had sufficient 
diagnostic power in the GCiMS profiles to allow complete 
differentiation between the two groups. Among these com- 
pounds acetone, methylethylketone and n-propanol were 
identified with a classification accuracy of 93%. In a more 
recent study conducted by O’Neil et al. in 1988, a group of 
patients, diagnosed with the early stages of lung cancer, are 
found to have 9 compounds which were identified as poten- 
tial biomarkers. Table 1 gives the listing of compounds in 
expired-air samples from lung cancer patients with >90% 
occurrence. More recently, Phillips and Qreenberg in 1992, 
studied VOC’s in alveolar breath using the ion trap detection 
techniques. 
TABLE 1 
Listing of Compounds in Expired-Air samples from lung cancer patients 
[Occurrence >90%) 
Chemical Compound } Formula 
Propenal C3H4O 
Acetone C3H60 
2-Butanone C4H,0 Phenol 
C,H,O Benzaldehvde C,H,OAcetophenone 
C,H,O Nonanal C,Hl,O 
Ethylpropanoate C5H,0, Methylisobutenoate 
C5HS02 
Although these potential markers for particular diseases 
such as lung cancer are in much higher concentration in the 
breath of patients than that of healthy subjects, they are still 
at a concentration level of ppb or lower. This concentration 
level (ppb) is below or near the limits of sensitivity of 
existing instrumentation. The most abundant compounds in 
the normal human breath isoprene and acetone are present in 
only nanomolar quantities whereas several other compounds 
are present in picomolar concentrations or lower. Research 
and development of a new on-line highly sensitive analytical 
methods are necessary for a reliable clinical diagnosis for 
the early stage of this disease. The apparatus and method- 
ology of the invention provides the tool for such research. 
Much development has been conducted toward using IMS 
for the detection of drug vapors, including illicit drugs such 
as cocaine, marijuana and heroin. The proposed detector has 
a potential for evolving into a hand-held illicit drug detector 
as well as an explosives detector (nitro compounds etc.) 
which could be utilized in airport security systems for 
concealed explosives. 
Similarly, a rugged detector with very high sensitivity 
based upon the technique proposed here, and incorporated in 
a remote-control rover, could be used in the battlefield for 
detecting chemical and biological warfare agents. Hand-held 
5 models could be used for treaty monitoring purposes. 
Many alterations and modifications may be made by those 
having ordinary skill in the art without departing from the 
spirit and scope of the invention. Therefore, it must be 
understood that the illustrated embodiment has been set 
forth only for the purposes of example and that it should not 
be taken as limiting the invention as defined by the following 
claims. For example, notwithstanding the fact that the ele- 
ments of a claim are set forth below in a certain combination, 
it must be expressly understood that the invention includes 
other combinations of fewer, more or different elements, 
which are disclosed in above even when not initially claimed 
in such combinations. 
The words used in this specification to describe the 
invention and its various embodiments are to be understood 
not only in the sense of their commonly defined meanings, 
20 but to include by special definition in this specification 
structure, material or acts beyond the scope of the commonly 
defined meanings. Thus if an element can be understood in 
the context of this specification as including more than one 
meaning, then its use in a claim must be understood as being 
25 generic to all possible meanings supported by the specifi- 
cation and by the word itself. 
The definitions of the words or elements of the following 
claims are, therefore, defined in this specification to include 
not only the combination of elements which are literally set 
30 forth, but all equivalent structure, material or acts for 
performing substantially the same function in substantially 
the same way to obtain substantially the same result. In this 
sense it is therefore contemplated that an equivalent substi- 
tution of two or more elements may be made for any one of 
35 the elements in the claims below or that a single element 
may be substituted for two or more elements in a claim. 
Although elements may be described above as acting in 
certain combinations and even initially claimed as such, it is 
to be expressly understood that one or more elements from 
40 a claimed combination can in some cases be excised from 
the combination and that the claimed combination may be 
directed to a subcombination or variation of a subcombina- 
tion. 
Insubstantial changes from the claimed subject matter as 
45 viewed by a person with ordinary skill in the art, now known 
or later devised, are expressly contemplated as being equiva- 
lently within the scope of the claims. Therefore, obvious 
substitutions now or later known to one with ordinary skill 
in the art are defined to be within the scope of the defined 
The claims are thus to be understood to include what is 
specifically illustrated and described above, what is concep- 
tionally equivalent, what can be obviously substituted and 
also what essentially incorporates the essential idea of the 
10 
so elements. 
55 invention. 
We claim: 
1. An apparatus comprising: 
an ionizing chamber to generate a plasma of reactant ions 
outside of the presence of the molecules of interest; 
60 a reaction chamber communicated with the ionizing 
chamber into which reaction chamber the reactant ions 
are disposed and in which reaction chamber the reac- 
tant ions selectively chemically react with molecules of 
interest having a higher proton affinity than the reactant 
ions to produce substantially only singly ionized prod- 
uct ions without appreciable fragmentation of the mol- 
ecules of interest; and 
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an ion mobility spectrometer communicated with the 
2. The apparatus of claim 1 where the ionizing chamber 
comprises a cathode and anode between which a potential 
difference is applied for the purpose of creating a plasma of s 
reactant ions in the ionizer for injection into the reaction 
chamber. 
3, The apparatus of claim 2 where the cathode of the 
ionizing chamber is hollow and symmetric about a 
longitudinal axis defined through the cathode. 
are cylindrical and commonly aligned along the common 
longitudinal axis. 
5. The apparatus of claim 3 where the hollow cathode of 
the ionizing chamber and reaction chamber are aligned 15 
along the common longitudinal axis to define an axial ion 
drift region through the hollow cathode and anode, and 
reaction chamber. 
6. The apparatus of claim 1 further comprising a sample 
probe disposed between the ionizing chamber and reaction 
chamber to provide pulsatile injection of reactant ions into 
the reaction chamber from the ionizing chamber. 
7. The apparatus of claim 6 where the ionizing chamber 
and reaction chamber are aligned along the common longi- 
tudinal axis to define an axial ion drift region through the 
hollow cathode and anode, and reaction chamber so that a 
pusatile grouping of product ions are generated in ion drift 
region in the reaction chamber. 
8. The apparatus of claim 7 wherein each grouping of 
product ions are longitudinally spread in the drift region 
according to mobility and delivered in such spread group- 
ings to the ion mobility spectrometer. 
9. The apparatus of claim 6 further comprising a decel- 
eration lens disposed between the reaction chamber and the 
ion mobility spectrometer to control velocity of product ions 
form the reaction chamber to the ion mobility spectrometer. 
10. The apparatus of claim 1 where the reactant ions are 
selected according to a proton affinity to selectively soft 
ionize the molecules of interest without fragmentation of the 
molecule of interest. 
chemically reacting the reactant ions with molecules of 
interest to produce product ions in the reaction cham- 
ber; and 
detecting product ions in an ion mobility spectrometer 
communicated with the reaction chamber. 
12. The method of claim 11 where generating a Plasma of 
reactant ions in an ionizing chamber comprises generating 
the plasma in a hollow cathode defining an ion drift region 
therein when a potential difference is applied between the 
anode and cathode. 
in a hollow cathode comprises generating the plasma in a 
hollow cathode which are symmetric about a common 
longitudinal axis defined through the hollow cathode and 
hollow anode, 
14, ne method of claim 13 where generating the plasma 
in a symmetric hollow cathode comprises generating the 
Dlasma in a hollow cathode which are cvlindrical and 
reaction chamber to detect the product ions. 
4, The apparatus of claim 3 where the cathode and anode 13. The method Of l2 where generating the plasma 
11. A method comprising: 
generating a plasma of reactant ions in an ionizing cham- 
injecting the plasma of reactant ions into a reaction 
ber; 
chamber; 
commonly aligned along the common longitudinal axis. 
15. The method of claim 11 where generating the plasma 
20 in the ionizing chamber and reaction chamber comprises 
generating the plasma in an ionizing chamber and reaction 
chamber which are aligned along the common longitudinal 
axis to define an axial ion drift region through the hollow 
cathode and anode, and reaction chamber. 
16. The method of claim 11 where injecting the plasma of 
reactant ions into a reaction chamber comprises providing 
pulsatile injection of reactant ions into the reaction chamber 
from the ionizing chamber. 
17. The method of claim 16 where providing pulsatile 
3o injection of reactant ions comprises generating a pusatile 
grouping of product ions in ion drift region in the reaction 
chamber. 
18. The method of claim 17 where generating a pusatile 
grouping of product ions comprises spreading each grouping 
3s of product ions longitudinally in the drift region according 
to mobility and delivering the spread groupings to the ion 
mobility spectrometer. 
19. The method of claim 16 further comprising deceler- 
ating the grouped product ions to control their velocity from 
20. The method of claim 11 where generating a plasma of 
reactant ions provides the reactant ions which are selected 
according to a proton affinity to selectively soft ionize the 
molecules of interest without substantial probability of frag- 
2s 
4o the reaction chamber to the ion mobility spectrometer. 
4s mentation. 
injecting molecules of interest into the reaction chamber; * * * * *  
